BR112018013829A2 - método de preparação de isótopo. - Google Patents

método de preparação de isótopo.

Info

Publication number
BR112018013829A2
BR112018013829A2 BR112018013829A BR112018013829A BR112018013829A2 BR 112018013829 A2 BR112018013829 A2 BR 112018013829A2 BR 112018013829 A BR112018013829 A BR 112018013829A BR 112018013829 A BR112018013829 A BR 112018013829A BR 112018013829 A2 BR112018013829 A2 BR 112018013829A2
Authority
BR
Brazil
Prior art keywords
exchange resin
eluting
solution
strong
base anion
Prior art date
Application number
BR112018013829A
Other languages
English (en)
Portuguese (pt)
Inventor
Mantzilas Dimitrios
Roger Karlson Jan
Tjelmeland Ostby Judit
Original Assignee
Bayer As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer As filed Critical Bayer As
Publication of BR112018013829A2 publication Critical patent/BR112018013829A2/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/04—Processes using organic exchangers
    • B01J41/05—Processes using organic exchangers in the strongly basic form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/04—Processes using organic exchangers
    • B01J39/05—Processes using organic exchangers in the strongly acidic form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
    • B01J49/60—Cleaning or rinsing ion-exchange beds
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F15/00—Compounds of thorium
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001—Recovery of specific isotopes from irradiated targets

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
BR112018013829A 2016-01-05 2016-12-29 método de preparação de isótopo. BR112018013829A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1600154.7A GB201600154D0 (en) 2016-01-05 2016-01-05 Isotope preparation method
PCT/EP2016/082835 WO2017118591A1 (en) 2016-01-05 2016-12-29 Isotope preparation method

Publications (1)

Publication Number Publication Date
BR112018013829A2 true BR112018013829A2 (pt) 2018-12-11

Family

ID=55406715

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018013829A BR112018013829A2 (pt) 2016-01-05 2016-12-29 método de preparação de isótopo.

Country Status (21)

Country Link
US (2) US20190009265A1 (zh)
EP (1) EP3400082A1 (zh)
JP (1) JP7017511B2 (zh)
KR (1) KR20180099705A (zh)
CN (1) CN108472555A (zh)
AR (1) AR107299A1 (zh)
AU (1) AU2016384271B2 (zh)
BR (1) BR112018013829A2 (zh)
CA (1) CA3010190C (zh)
CL (1) CL2018001844A1 (zh)
CO (1) CO2018007037A2 (zh)
GB (1) GB201600154D0 (zh)
IL (1) IL259644B (zh)
MX (1) MX2018008340A (zh)
PE (1) PE20181454A1 (zh)
RU (1) RU2768732C2 (zh)
SG (2) SG10202006429YA (zh)
TW (1) TWI733732B (zh)
UA (1) UA125583C2 (zh)
UY (1) UY37066A (zh)
WO (1) WO2017118591A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3682959A1 (en) * 2019-01-16 2020-07-22 Sck Cen Purification of actinium
JP7154414B2 (ja) 2019-07-02 2022-10-17 日本メジフィジックス株式会社 ２２６Ｒａ含有溶液の精製方法、２２６Ｒａターゲットの製造方法および２２５Ａｃの製造方法
CN111398469B (zh) * 2020-04-09 2020-10-27 中国科学院地质与地球物理研究所 一种小样品量的第四纪土壤碳酸盐的定年方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5809394A (en) * 1996-12-13 1998-09-15 Battelle Memorial Institute Methods of separating short half-life radionuclides from a mixture of radionuclides
NO310544B1 (no) * 1999-01-04 2001-07-23 Algeta As Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
NO313180B1 (no) * 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Bensökende alfapartikkel emitterende radiofarmasöytika
US20060228297A1 (en) * 2003-04-15 2006-10-12 Roy Larsen Thorium-227 for use in radiotherapy of soft tissue disease
EP1617876B1 (en) * 2003-04-15 2014-05-14 Algeta AS Thorium-227 for use in radiotherapy of soft tissue disease
KR101247836B1 (ko) * 2005-06-17 2013-03-28 와이어쓰 엘엘씨 항 ａ 베타 항체의 정제 방법
GB201002508D0 (en) * 2010-02-12 2010-03-31 Algeta As Product
GB201007354D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method
GB201208309D0 (en) * 2012-05-11 2012-06-27 Algeta As Complexes
US9951399B2 (en) * 2014-04-09 2018-04-24 Los Alamos National Security, Llc Separation of protactinum, actinium, and other radionuclides from proton irradiated thorium target

Also Published As

Publication number Publication date
CL2018001844A1 (es) 2018-10-26
MX2018008340A (es) 2018-09-17
TW201726586A (zh) 2017-08-01
UA125583C2 (uk) 2022-04-27
AR107299A1 (es) 2018-04-18
KR20180099705A (ko) 2018-09-05
TWI733732B (zh) 2021-07-21
RU2768732C2 (ru) 2022-03-24
CA3010190A1 (en) 2017-07-13
JP7017511B2 (ja) 2022-02-08
RU2018127822A3 (zh) 2020-03-17
EP3400082A1 (en) 2018-11-14
IL259644B (en) 2022-08-01
CN108472555A (zh) 2018-08-31
UY37066A (es) 2017-08-31
GB201600154D0 (en) 2016-02-17
AU2016384271B2 (en) 2022-05-12
US11452999B2 (en) 2022-09-27
US20200406247A1 (en) 2020-12-31
SG11201805459UA (en) 2018-07-30
WO2017118591A1 (en) 2017-07-13
CO2018007037A2 (es) 2018-07-19
US20190009265A1 (en) 2019-01-10
PE20181454A1 (es) 2018-09-12
IL259644A (en) 2018-07-31
SG10202006429YA (en) 2020-08-28
JP2019509467A (ja) 2019-04-04
AU2016384271A1 (en) 2018-06-21
RU2018127822A (ru) 2020-02-06
CA3010190C (en) 2023-07-11

Similar Documents

Publication Publication Date Title
BR112012027929A2 (pt) método para a geração de 223ra de pureza farmaceuticamente tolerável, 223ra, e, composição farmacêutica
BR112015023168A8 (pt) composição de dicetopiperazina cristalina, métodos de produção de partículas de dicetopiiperazina,de produção de uma composição e de tratamento e uso de uma composição de dicetopiperazina cristalina
BR112018013829A2 (pt) método de preparação de isótopo.
BR112019007369A2 (pt) anticorpos anti-lag-3 e métodos de uso dos mesmos
AR088460A1 (es) Formulaciones de etanercept estabilizadas con aminoacidos
BR112017001860A2 (pt) peptídeo sintético, composição farmacêutica, métodos, regime de dosagem, e, anticorpo monoclonal
BR112015014333A2 (pt) compostos antivirais
BR112015032696A2 (pt) composição à base de resina epoxídica como carga para células em forma de colmeia
BR112016017996A2 (pt) 6-heteroariloxi- or 6-ariloxi-quinolina-2-carboxamidas e método de uso
CL2018003178A1 (es) Composición farmacéutica
BRPI0907789A2 (pt) derivaldos 16-alfa e 17-alfa de glicocorticosteroides e seus usos
BR112017010069A2 (pt) redução seletiva de resíduos cisteína em anticorpos para il-17
BR112018014123A2 (pt) formulação farmacêutica aquosa estável.
BR112015031329A2 (pt) composições compreendendo ciclodextrina e ácido hialurônico reticulado
BR112022003740A2 (pt) Anticorpos anti-cd96 e métodos de uso dos mesmos
BR112015024621A8 (pt) usos de dose unitária de unidades formadoras de colônia de c. novyi, composição farmacêutica compreendendo a referida dose unitária, kit para tratar ou atenuar um efeito de um tumor sólido presente em um ser humano e dose unitária de unidades formadoras de colônia de c. novyi
BR112018017174A2 (pt) conjugados de aminoácido e peptídeo e processo de conjugação
BR112022012118A2 (pt) Kit para preparar uma composição de nanopartículas
EA201991023A1 (ru) Фармацевтическая композиция для парентерального введения, содержащая карглумовую кислоту
CL2016001375A1 (es) Composición, que comprende agente bioactivo (inmunógeno) dispersado en gotitas de aceite, polímero de recubrimiento entérico, un polímero mucoadhesivo, su método de preparación y uso para la administración oral de un agente bioactivo.
PH12020500278A1 (en) Pharmaceutical composition and method for preparing same
BR112021002565A8 (pt) Composto, sal farmaceuticamente aceitável, tautômero ou estereoisômero do mesmo, composição farmacêutica, processo para a síntese e uso do dito composto
BR112015021630A2 (pt) estabilização de fármacos sensíveis à umidade
BR112018004719A2 (pt) composto de fluoroindola, composição farmacêutica, método para o tratamento de uma desordem relacionada a receptor muscarínico m1 e uso do composto
BR112014026156A2 (pt) composição de epóxi de baixa densidade com baixa absorção de água

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.